Format

Send to

Choose Destination
Infect Dis Clin North Am. 1999 Mar;13(1):11-26, v.

Genetic vaccines.

Author information

1
Vaccine Research Department, Heska Corporation, Fort Collins, Colorado, USA. haynesj@heska.com

Abstract

In a few short years, genetic vaccine technology has moved rapidly from a novel concept to an important strategy for the development of human and veterinary vaccines, for numerous indications. This article discusses current areas in which further refinements in technology will influence a variety of infectious disease treatments, including intramuscular and intradermal inoculation, gene gun inoculation, the mechanism of antigen presentation, and the use of genetic adjuvants.

PMID:
10198789
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center